Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reaffirmed by investment analysts at FinnCap in a note issued to investors on Thursday, Analyst RN reports. They currently have a GBX 202 ($3.39) price objective on the stock. FinnCap’s price objective indicates a potential upside of 49.08% from the company’s current price.

Shares of Vectura Group PLC (LON:VEC) traded down 0.37% during mid-day trading on Thursday, hitting GBX 135.50. The stock had a trading volume of 309,661 shares. Vectura Group PLC has a 52 week low of GBX 76.00 and a 52 week high of GBX 171.50. The stock’s 50-day moving average is GBX 145.5 and its 200-day moving average is GBX 136.4. The company’s market cap is £459.6 million.

A number of other firms have also recently commented on VEC. Analysts at Investec downgraded shares of Vectura Group PLC to a “hold” rating in a research note on Wednesday, April 9th. They now have a GBX 170 ($2.86) price target on the stock. Separately, analysts at Edison Group reiterated a “positive” rating on shares of Vectura Group PLC in a research note on Monday, March 31st. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Vectura Group PLC from GBX 200 ($3.36) to GBX 230 ($3.86) in a research note on Thursday, March 20th. They now have an “overweight” rating on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of GBX 165.78 ($2.78).

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.